Results

Total Results: 2,080 records

Showing results for "drug".

81. Migraine-Adults-Executive-130408 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
    April 01, 2013 - , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) influence results? … care, patient education, drug surveillance, or interactive drug monitoring) influence results? … care, patient education, drug surveillance, or interactive drug monitoring) influence results? … Food and Drug Administration.

82. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
    December 21, 2010 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … than drug-supplement interactions, and there is a clear need to synthesize information on drug-supplement … . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)?

83. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - The drug has been granted orphan drug designation. … Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. 3. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html http://investors.vrtx.com/releasedetail.cfm? … Oral treprostinil new drug application accepted by FDA for review. [internet].

84. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Ivacaftor in combination with another experimental CF drug, VX-809, has also been shown to improve … Even for patients with prescription drug coverage, copayments are expected to be significant. … Available: http://www.vrtx.com/current- projects/drug-candidates/vx-770.html. 3. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html http://investors.vrtx.com/releasedetail.cfm?

85. Dietary Supplements in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research
    April 30, 2012 - This also poses risks of adverse events from supplement-drug interactions and nonadherence associated … by patients with cardiovascular disease, we examined benefits, harms, and effects on cardiovascular drug … reviewers included experimental and observational studies comparing a supplement plus cardiovascular drug … versus drug alone published in English or German; other languages were excluded due to concerns with … Conclusions Limitations of the evidence base precluded meaningful conclusions across most supplement-drug

86. S29 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
    October 01, 2007 - 1 study drug was a newer drug (“on the market for 1 yr”)? … Compare drug to nondrug alternative (vs. drug-drug comparison) Possibly acceptable if the treatments … Newer drug (1 drug on the market for only a year vs. both drugs on the market for “quite a while”) More … “You are making one drug your preferred drug; does that also mean you are going to take the other drug … and make it your nonpreferred drug?

87. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
    September 12, 2019 - [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer

88. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
    January 01, 2011 - are the long-term (> 90-day) mortality, morbidity, and functional outcomes associated with various drug … Compare two newer drug therapies, both FDA approved, for the treatment of PAH (inhaled treprostinil … Compare combination drug therapies to monotherapy drug treatment Pulmonary Arterial Hypertension … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy … In order to optimize PAH care, newer information regarding the latest drug therapies and combination

89. S81 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - for drug-induced delirium/ psychosis. … In contrast, few ICD-9-CM codes specifically describe drug exposure. … A wide variety of commonly used drug classes cause delir- ium. … Aggregate variables of ICD-9-CM codes that indicated drug- TABLE 1. … Drug Saf. 1999;20:109–117. 14. Hurdle JF, Weir CR, Roth B, et al.

90. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … b. . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)? … of the mechanisms of absorption and distribution of an administered drug, the rate at which a drug

91. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - We used the WHO drug classification system that does not include tonabersat. … We corrected the drug class for this medication following your recommendations. 3. … We added the tables with the numbers of the enrolled for each drug class. … We found no trials that reported drug effects in gender subgroups. … We requested the FDA review of this drug.

92. The Incident User Design in Comparative Effectiveness Research | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/incident-user-design/research
    May 15, 2012 - therapy and ignoring the duration of drug use. … For example, some propensity scores predict a combination of incident drug use, persistence with a drug … marketed drug. … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA. … Pharmacoepidemiol Drug Safety 2006;15:81-92. 15. UKPDS Group.

93. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
    May 01, 2012 - therapy and ignoring the duration of drug use. … For example, some propensity scores predict a combination of incident drug use, persistence with a drug … newly marketed drug. … or class be compared with incident users of another drug or class? … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA.

94. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
    November 01, 2023 - Our concluding assessment of this drug remains the same as the prior 2014 review. … We reviewed studies for three medications with Food and Drug Administration approval for alcohol use … As before, we included all medications with Food and Drug Administration indications for alcohol use … https://effectivehealthcare.ahrq.gov/products /alcohol-misuse-drug-therapy/research 2. … Drug and placebo responses in chronic alcoholics. Psychiatric Research Reports. 1968 Mar;24:44-60.

95. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
    May 24, 2017 - Timeline Mar. 29, 2017 Topic Initiated May. 24, 2017 Research Protocol Jul. 16, 2018 Systematic Review Drug … Research Protocol May 24, 2017 Download Main Document PDF 279.4 KB Previous Report: Drug … However, data on disease-modifying antirheumatic drug (DMARD) use in the first 3 months are limited. … Choosing a RA treatment drug can be difficult with these populations. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update [Internet].

96. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
    August 01, 2016 - Food and Drug Administration for AUD include acamprosate (Campral®, thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD.

97. For adults and children with asthma what is the effectiveness of the Buteyko Breathing method on reducing bronchodilator and inhaled steroid use and improving health status? | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-adults-and-children-with-asthma-what-is-the-effectiveness-of-the-buteyko-breathing-method-on-reducing-bronchodilator-and-inhaled-steroid-use-and-improving-health-status
    September 01, 2009 - and clinics in the U.K. and other parts of Europe, Australia, New Zealand and Canada - places where drug … ultimate outcome is that patients who can reduce their ventilation no longer require any or as much drug … Appropriateness for EHC Program Does your question include a health care drug, intervention, device … It is cost and clinically effective and yet no one is told about it because doctors and drug companies … It does involve patient compliance over and above simply ingesting a drug and so it is a method that

98. Medicamentos para tratar el trastorno por consumo de alcohol: Revisión de la investigación para adultos (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_espanol.pdf
    November 01, 2016 - � Acamprosato (Campral®): Este medicamento fue aprobado por la Food and Drug Administration (FDA,

99. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer

100. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research-protocol
     July 01, 2010 - drug, each newer antiepileptic drug will be compared individually against the older antiepileptic drug … innovator antiepileptic drug group, each generic antiepileptic drug will be compared individually against … the innovator antiepileptic drug (as a separate trial) by dividing the innovator antiepileptic drug … A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product … drug therapy.fs. randomly.ab. trial.ab. groups.ab.